TheraRadar
← Back
Data updated: Mar 29, 2026

WOCKHARDT USA

Infectious DiseaseOncologyGastroenterology
Generics

WOCKHARDT USA is a generic drug manufacturer focused on Infectious Disease, Oncology, Gastroenterology.

2008
Since
4
Drugs
-
Trials
28
Approved (2yr)

Key Drugs

No active drugs

Top Drug Revenues Pro

Loading...

Revenue Over Time Pro

Loading...

Recent Activity

EXTENDED PHENYTOIN SODIUM 2026-01-02
OCTREOTIDE ACETATE 2025-12-12
GRANISETRON HYDROCHLORIDE 2025-03-24
Labeling
GRANISETRON HYDROCHLORIDE 2025-03-17
OCTREOTIDE ACETATE 2024-10-25
Labeling
OCTREOTIDE ACETATE 2024-09-30
Labeling
OCTREOTIDE ACETATE (PRESERVATIVE FREE) 2024-09-25
Labeling
OCTREOTIDE ACETATE (PRESERVATIVE FREE) 2024-09-25
Labeling
SEC Filings Pro
Loading...

Therapeutic Areas

Score weights: Approved drugs ×3, Phase 3 ×2, Phase 2 ×1, Phase 1 ×0.5

Infectious Disease 43%
0 drugs Phase 3: 2 Phase 2: 1 Phase 1: 2
Oncology 21%
1 drugs
Gastroenterology 21%
1 drugs
Dermatology 14%
0 drugs Phase 3: 1

Pipeline Forecast

Loading...

Upcoming Trial Milestones Pro

Loading...

Patent Cliff Pro

Loading...

Competitors by Therapeutic Area

Pfizer big-pharma
Oncology, Infectious Disease, Dermatology, Gastroenterology
Baxter specialty
Infectious Disease, Oncology, Dermatology
Bristol-Myers Squibb big-pharma
Oncology, Gastroenterology, Infectious Disease
CASPER PHARMA LLC big-pharma
Infectious Disease, Oncology, Gastroenterology, Dermatology
COSETTE other
Dermatology, Infectious Disease, Oncology